PTEN and cancer: Dysregulation of Wnt/β-catenin signaling induced by PTEN loss may enhance cancer stem cell properties, fostering tumorigenesis and resistance to therapy [144], and PTEN deficiency may stimulate EMT through Wnt/β-catenin signaling, promoting metastasis and resistance to therapeutics [147].